Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

NSE:ADVENZYMES Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,077	1,138	964.2	2,674	1,919
Short-Term Investments	4,803	126.74	116.55	16.33	54.9
Trading Asset Securities	-	4,029	3,596	1,019	1,213
Cash & Short-Term Investments	5,879	5,293	4,676	3,709	3,187
Cash Growth	11.09%	13.18%	26.07%	16.38%	54.57%
Accounts Receivable	1,154	985.68	1,003	884.91	872.31
Other Receivables	-	15.9	20.06	63.54	23.55
Receivables	1,155	1,003	1,025	949.31	896.59
Inventory	1,573	1,485	1,240	1,209	938.81
Prepaid Expenses	-	39.63	23.23	20.97	19.66
Other Current Assets	191.19	277.9	257.09	155.55	117.89
Total Current Assets	8,799	8,097	7,221	6,044	5,160
Property, Plant & Equipment	3,146	3,073	2,888	2,718	2,510
Long-Term Investments	0.65	1.71	1.7	0.7	0.7
Goodwill	3,334	3,253	3,209	2,961	2,887
Other Intangible Assets	523.08	582.86	608.78	663.06	746.74
Long-Term Deferred Tax Assets	101.92	142.82	113.42	74.2	68.68
Other Long-Term Assets	307.76	203.84	176.73	215.04	187.96
Total Assets	16,213	15,355	14,218	12,676	11,562
Accounts Payable	172.01	157.59	242.21	178.97	152.17
Accrued Expenses	-	141.97	124.55	124.62	121.28
Short-Term Debt	-	175.8	49.89	19.2	46.92
Current Portion of Long-Term Debt	123.53	3.58	1.96	5.99	42.93
Current Portion of Leases	60.8	65.54	59.37	57.28	51.89
Current Income Taxes Payable	45.92	91.41	14.84	1.99	1.89
Other Current Liabilities	565.29	427.68	282.84	216.17	258.48
Total Current Liabilities	967.55	1,064	775.66	604.22	675.56
Long-Term Debt	91.83	66.52	72.77	73.53	93.16
Long-Term Leases	117.34	161.64	151	191.3	44.73
Long-Term Deferred Tax Liabilities	336.34	343.24	372.27	392.5	408.5
Other Long-Term Liabilities	13.71	1.71	0.93	3.1	3.69
Total Liabilities	1,527	1,644	1,377	1,272	1,236
Common Stock	223.76	223.65	223.65	223.6	223.46
Additional Paid-In Capital	-	821.31	821.31	813.55	789.56
Retained Earnings	-	10,711	9,945	9,022	8,016
Comprehensive Income & Other	13,985	1,485	1,360	826.43	680.3
Total Common Equity	14,209	13,241	12,351	10,886	9,709
Minority Interest	478.07	469.52	491.02	517.93	616.82
Shareholders' Equity	14,687	13,711	12,842	11,404	10,326
Total Liabilities & Equity	16,213	15,355	14,218	12,676	11,562
Total Debt	393.5	473.08	334.99	347.3	279.63
Net Cash (Debt)	5,486	4,820	4,341	3,362	2,908
Net Cash Growth	13.82%	11.02%	29.13%	15.63%	68.25%
Net Cash Per Share	49.00	43.08	38.83	30.05	25.99
Filing Date Shares Outstanding	111.74	111.82	111.82	111.8	111.73
Total Common Shares Outstanding	111.74	111.82	111.82	111.8	111.73
Working Capital	7,831	7,034	6,445	5,440	4,485
Book Value Per Share	127.16	118.41	110.45	97.37	86.90
Tangible Book Value	10,351	9,405	8,533	7,262	6,075
Tangible Book Value Per Share	92.64	84.11	76.31	64.96	54.38
Land	-	568.36	559.12	517.39	517.39
Buildings	-	730.58	723.47	627.92	587.94
Machinery	-	2,666	2,500	2,342	2,165
Construction In Progress	-	307.37	156.09	96.28	48.62
Leasehold Improvements	-	126.51	115.34	103.32	102.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.